Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by NobleFron Nov 28, 2020 9:47pm
841 Views
Post# 31995899

Twitter answer

Twitter answerThey answered my question on Twitter today about if they were behind schedule for the rollout of 165 cubes by the end of November and 400 by December.

They said they were 5-10 days behind that schedule.

Personnaly, I never believed and still don't believe they can rollout hundreds of cubes that fast because of HR (they need to find phlebotomists and it take time to find talent).

What keeps me in is the fact that the share price should be higher even if they can rollout just a fraction of what they said. 5-10 days behind schedule is better than expected for me. This would mean 165 cubes by the middle of December.

I still have a hard time believing they will achieve this but it would be awesome. Will definately buy even more if they manage to have 165 cubes by mid December and stock price doesn't react.

<< Previous
Bullboard Posts
Next >>